Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
Clinical trial NCT00002109 · COMPLETED
Trial details
- NCT number
- NCT00002109
- Sponsor
- Immunobiology Research Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.